144 related articles for article (PubMed ID: 26398186)
1. Biology of Hepatocellular Carcinoma.
Critelli RM; De Maria N; Villa E
Dig Dis; 2015 Sep; 33(5):635-41. PubMed ID: 26398186
[TBL] [Abstract][Full Text] [Related]
2. Genetic profiling of human hepatocellular carcinoma.
Lee JS; Thorgeirsson SS
Semin Liver Dis; 2005; 25(2):125-32. PubMed ID: 15918141
[TBL] [Abstract][Full Text] [Related]
3. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
Okamoto M; Utsunomiya T; Wakiyama S; Hashimoto M; Fukuzawa K; Ezaki T; Hanai T; Inoue H; Mori M
Ann Surg Oncol; 2006 Jul; 13(7):947-54. PubMed ID: 16788756
[TBL] [Abstract][Full Text] [Related]
4. Prediction of disease-free survival in hepatocellular carcinoma by gene expression profiling.
Lim HY; Sohn I; Deng S; Lee J; Jung SH; Mao M; Xu J; Wang K; Shi S; Joh JW; Choi YL; Park CK
Ann Surg Oncol; 2013 Nov; 20(12):3747-53. PubMed ID: 23800896
[TBL] [Abstract][Full Text] [Related]
5. Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma.
Woo HG; Park ES; Cheon JH; Kim JH; Lee JS; Park BJ; Kim W; Park SC; Chung YJ; Kim BG; Yoon JH; Lee HS; Kim CY; Yi NJ; Suh KS; Lee KU; Chu IS; Roskams T; Thorgeirsson SS; Kim YJ
Clin Cancer Res; 2008 Apr; 14(7):2056-64. PubMed ID: 18381945
[TBL] [Abstract][Full Text] [Related]
6. Comparative and integrative functional genomics of HCC.
Lee JS; Thorgeirsson SS
Oncogene; 2006 Jun; 25(27):3801-9. PubMed ID: 16799621
[TBL] [Abstract][Full Text] [Related]
7. Gene signatures in the management of hepatocellular carcinoma.
Hoshida Y; Moeini A; Alsinet C; Kojima K; Villanueva A
Semin Oncol; 2012 Aug; 39(4):473-85. PubMed ID: 22846864
[TBL] [Abstract][Full Text] [Related]
8. Genome-scale profiling of gene expression in hepatocellular carcinoma: classification, survival prediction, and identification of therapeutic targets.
Lee JS; Thorgeirsson SS
Gastroenterology; 2004 Nov; 127(5 Suppl 1):S51-5. PubMed ID: 15508103
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma.
Jia HL; Ye QH; Qin LX; Budhu A; Forgues M; Chen Y; Liu YK; Sun HC; Wang L; Lu HZ; Shen F; Tang ZY; Wang XW
Clin Cancer Res; 2007 Feb; 13(4):1133-9. PubMed ID: 17317821
[TBL] [Abstract][Full Text] [Related]
11. Expression analysis of THOP1 in background liver, a prognostic predictive factor in hepatocellular carcinoma, extracted by multiarray analysis.
Nomoto S; Hishida M; Inokawa Y; Takano N; Kanda M; Nishikawa Y; Fujii T; Koike M; Sugimoto H; Kodera Y
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S443-50. PubMed ID: 24604581
[TBL] [Abstract][Full Text] [Related]
12. Predicting the prognosis of hepatocellular carcinoma using gene expression.
Chang SH; Suh KS; Yi NJ; Lee KH; Kim BY; Jang JJ
J Surg Res; 2011 Dec; 171(2):524-31. PubMed ID: 20828739
[TBL] [Abstract][Full Text] [Related]
13. Sex-based molecular profiling of hepatitis C virus-related hepatocellular carcinoma.
Takemoto N; Iizuka N; Yamada-Okabe H; Hamada K; Tamesa T; Okada T; Hashimoto K; Sakamoto K; Takashima M; Miyamoto T; Uchimura S; Hamamoto Y; Oka M
Int J Oncol; 2005 Mar; 26(3):673-8. PubMed ID: 15703822
[TBL] [Abstract][Full Text] [Related]
14. Exploring genomic profiles of hepatocellular carcinoma.
Woo HG; Park ES; Thorgeirsson SS; Kim YJ
Mol Carcinog; 2011 Apr; 50(4):235-43. PubMed ID: 21465573
[TBL] [Abstract][Full Text] [Related]
15. Molecular prediction of early recurrence after resection of hepatocellular carcinoma.
Yoshioka S; Takemasa I; Nagano H; Kittaka N; Noda T; Wada H; Kobayashi S; Marubashi S; Takeda Y; Umeshita K; Dono K; Matsubara K; Monden M
Eur J Cancer; 2009 Mar; 45(5):881-9. PubMed ID: 19167881
[TBL] [Abstract][Full Text] [Related]
16. Molecular profiling of hepatocellular carcinomas by cDNA microarray.
Zhang LH; Ji JF
World J Gastroenterol; 2005 Jan; 11(4):463-8. PubMed ID: 15641127
[TBL] [Abstract][Full Text] [Related]
17. A blood-based three-gene signature for the non-invasive detection of early human hepatocellular carcinoma.
Shi M; Chen MS; Sekar K; Tan CK; Ooi LL; Hui KM
Eur J Cancer; 2014 Mar; 50(5):928-36. PubMed ID: 24332572
[TBL] [Abstract][Full Text] [Related]
18. Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling.
Nam SW; Park JY; Ramasamy A; Shevade S; Islam A; Long PM; Park CK; Park SE; Kim SY; Lee SH; Park WS; Yoo NJ; Liu ET; Miller LD; Lee JY
Hepatology; 2005 Oct; 42(4):809-18. PubMed ID: 16175600
[TBL] [Abstract][Full Text] [Related]
19. Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis.
Wang W; Yang LY; Huang GW; Lu WQ; Yang ZL; Yang JQ; Liu HL
Br J Cancer; 2004 Jun; 90(12):2349-55. PubMed ID: 15150600
[TBL] [Abstract][Full Text] [Related]
20. A seven-gene set associated with chronic hypoxia of prognostic importance in hepatocellular carcinoma.
van Malenstein H; Gevaert O; Libbrecht L; Daemen A; Allemeersch J; Nevens F; Van Cutsem E; Cassiman D; De Moor B; Verslype C; van Pelt J
Clin Cancer Res; 2010 Aug; 16(16):4278-88. PubMed ID: 20592013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
